Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report-Reference-Cited by-同舟云学术

Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report

Published:2020-12-15 Issue:12 Volume:12 Page:1456-1463
ISSN:1948-5204
Container-title:World Journal of Gastrointestinal Oncology
language:
Short-container-title:WJGO

Author:

Marco Mariacristina Di,Carloni Riccardo,Lorenzo Stefania De,Mosconi Cristina,Palloni Andrea,Grassi Elisa,Filippini Daria Maria,Ricci Angela Dalia,Rizzo Alessandro,Federico Alessandro Di,Santini Donatella,Turchetti Daniela,Ricci Claudio,Ingaldi Carlo,Alberici Laura,Minni Francesco,Golfieri Rita,Brandi Giovanni,Casadei Riccardo

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,Oncology

Reference27 articles.

1. 851 resected cystic tumors of the pancreas: A 33-year experience at the Massachusetts General Hospital

2. Characteristics and Outcomes of Pancreatic Cancer by Histological Subtypes

3. Favourable prognosis of cystadeno- over adenocarcinoma of thepancreas after curative resection

4. Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors

5. Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High likelihood of BRCA2 reversion mutation in pancreatic cancer post-platinum-based chemotherapy: a case study;International Cancer Conference Journal;2024-08-16

2. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications;Translational Oncology;2023-01

3. Antineoplastics/folinic acid;Reactions Weekly;2021-02